Ultralife Stock Price, News & Analysis

Ultralife Corporation (NASDAQ: ULBI) is a manufacturing company that serves its markets with products and services ranging from power solutions to communications and electronics systems. According to the company’s public disclosures, Ultralife serves government/defense and commercial customers across the globe, aligning with the primary battery manufacturing industry and the broader manufacturing sector.

Ultralife is headquartered in Newark, New York and, as noted in its SEC filings, is incorporated in Delaware and lists its common stock on the NASDAQ Stock Market under the symbol ULBI. The company reports that it has operations in North America, Europe and Asia, reflecting an international operating footprint that supports both government and commercial programs.

Business Segments and Core Activities

Ultralife’s business is organized into two primary segments: Battery & Energy Products and Communications Systems. These segments are consistently referenced in the company’s earnings releases and SEC filings as the basis for its revenue reporting and operational analysis.

The Battery & Energy Products segment includes lithium 9-volt, cylindrical and various other non-rechargeable batteries, as described in prior company information. Public financial statements show that this segment accounts for the majority of Ultralife’s reported revenues. The company also references power solutions in its descriptions, indicating that this segment is central to its role in primary battery manufacturing and related energy products.

The Communications Systems segment is focused on communications and electronics systems. In its press releases, Ultralife reports sales from this segment separately from Battery & Energy Products and discusses integrated systems and communications-related offerings in the context of this business line. Together, these two segments form the structure through which Ultralife reports revenues, gross profit and operating income.

End Markets and Customers

Ultralife states that it serves government/defense and commercial customers. Within these broad categories, its disclosures refer to markets such as government/defense, medical, oil & gas and other industrial applications through the Battery & Energy Products segment, and defense-related customers within Communications Systems. The company also notes that it serves customers across the globe, indicating a mix of U.S. and international demand.

In its earnings releases, Ultralife highlights government/defense sales, including references to demand from a U.S.-based global prime contractor and international defense contractors. It also notes commercial sales trends in areas such as medical and oil & gas. These details illustrate how the company’s battery and communications offerings are applied in both defense and commercial settings.

Geographic Footprint and Exchange Listing

Ultralife reports that it has operations in North America, Europe and Asia. This geographic footprint is cited in multiple press releases describing the company. Its SEC filings confirm that the company’s common stock, with a par value of $0.10 per share, trades on the NASDAQ Stock Market under the symbol ULBI. The filings also specify that Ultralife is a Delaware corporation with its principal executive offices in Newark, New York.

Growth, Acquisitions and Operational Focus

Ultralife’s public communications describe an ongoing focus on product development, operational efficiency and integration of acquired businesses. The company reports that on October 31, 2024 it completed the acquisition of Electrochem Solutions, Inc. from Integer Holdings Corporation. Subsequent earnings releases discuss the contribution of Electrochem to the Battery & Energy Products segment and the impact of this acquisition on revenue, gross margin, operating expenses and debt.

The company has also disclosed actions to rationalize its manufacturing operations. For example, in its third quarter 2025 results release, Ultralife reports a decision to close its battery pack assembly facility in Calgary, Canada and relocate equipment and inventory to a facility in Houston, Texas. The company recorded a charge related to severance, lease costs and closure activities and indicated that this action is part of efforts to improve operational efficiency.

Across multiple quarters, Ultralife’s management commentary emphasizes initiatives such as lean and process improvement, supply chain resiliency, tariff mitigation, vertical integration in the oil & gas segment and continued investment in new product development. While specific financial figures vary by period, these themes appear consistently in the company’s descriptions of its strategy and operations.

Financial Reporting and Segment Performance

Ultralife provides detailed segment reporting in its consolidated financial statements. Revenues are broken out between Battery & Energy Products and Communications Systems, and the company reports gross profit, operating expenses, operating income or loss, and other expense items. It also discloses backlog and high-confidence orders at the end of various reporting periods, highlighting the volume of orders it expects to fulfill.

The company frequently discusses non-GAAP financial measures such as adjusted EBITDA and adjusted EPS. In its releases, Ultralife explains that adjusted EBITDA is defined as net income attributable to Ultralife Corporation before net interest expense, provision for income taxes, depreciation and amortization, and stock-based compensation expense, plus or minus certain non-recurring items. The company provides reconciliations of these non-GAAP measures to the most directly comparable GAAP measures in its published tables.

Regulatory Filings and Governance

Ultralife files periodic reports and current reports with the U.S. Securities and Exchange Commission. For example, Form 8-K filings dated August 7, 2025 and November 18, 2025 report the issuance of press releases regarding quarterly financial results, and a Form NT 10-Q (Form 12b-25) dated November 7, 2025 explains a brief delay in filing the Form 10-Q for the quarter ended September 30, 2025 due to the transition of Electrochem’s books and records to Ultralife’s systems.

An 8-K dated August 27, 2025 describes a change in Ultralife’s independent registered public accounting firm following the acquisition of certain assets of its prior auditor by another firm. The filing notes that the prior auditor’s reports on the company’s financial statements for the fiscal years ended December 31, 2023 and 2024 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, although the report on internal control over financial reporting identified a material weakness.

Stock and Capital Structure

Ultralife’s consolidated balance sheets show common stock, capital in excess of par value, accumulated deficit, accumulated other comprehensive loss and treasury stock as components of shareholders’ equity. The company also reports non-controlling interest related to certain subsidiaries. Long-term debt and its current portion are presented among liabilities, reflecting financing associated in part with the Electrochem acquisition.

Through these disclosures, Ultralife provides investors with information about its capital structure, including equity, debt and accumulated earnings or losses. While specific amounts change from period to period, the structure of the balance sheet and the presence of long-term debt, goodwill and other intangible assets are recurring features in the company’s financial statements.

Summary

In summary, Ultralife Corporation is a NASDAQ-listed manufacturing company headquartered in Newark, New York, operating through two main segments: Battery & Energy Products and Communications Systems. It serves government/defense and commercial customers worldwide with power solutions and communications and electronics systems. Public filings and earnings releases highlight its focus on integrating acquisitions, managing its global operations across North America, Europe and Asia, investing in new product development, and pursuing operational efficiency through supply chain, manufacturing and process initiatives.